These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3871947)
1. Human leukemia cell maturation induced by a T-cell lymphokine isolated from medium conditioned by normal lymphocytes. Leung K; Chiao JW Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1209-13. PubMed ID: 3871947 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of regulating human leukemia cell growth and differentiation by a lymphokine. Chiao JW; Abolhassani M; Leung K; Heil M Biochem Biophys Res Commun; 1989 Jun; 161(2):583-8. PubMed ID: 2786718 [TBL] [Abstract][Full Text] [Related]
3. Maturation inducer activity and the process of human myeloid leukemia cell differentiation. Chiao JW Blood Cells; 1987; 13(1-2):111-5. PubMed ID: 3311211 [TBL] [Abstract][Full Text] [Related]
4. Two separate differentiation inducing proteins for human myeloid leukemia cells and their isolation from normal lymphocytes. Abolhassani M; Riley WM; Feldman E; Arlin Z; Chiao JW Proc Soc Exp Biol Med; 1990 Nov; 195(2):288-91. PubMed ID: 2236110 [TBL] [Abstract][Full Text] [Related]
5. A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells. Santoli D; Tweardy DJ; Ferrero D; Kreider BL; Rovera G J Exp Med; 1986 Jan; 163(1):18-40. PubMed ID: 2416868 [TBL] [Abstract][Full Text] [Related]
6. Lymphokine inducing "terminal differentiation" of the human monoblast leukemia line U937: a role for gamma interferon. Ralph P; Harris PE; Punjabi CJ; Welte K; Litcofsky PB; Ho MK; Rubin BY; Moore MA; Springer TA Blood; 1983 Dec; 62(6):1169-75. PubMed ID: 6416332 [TBL] [Abstract][Full Text] [Related]
7. Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937. Harris PE; Ralph P; Litcofsky P; Moore MA Cancer Res; 1985 Jan; 45(1):9-13. PubMed ID: 2981161 [TBL] [Abstract][Full Text] [Related]
8. T lymphocyte-derived differentiation-inducing factor inhibits proliferation of leukemic and normal hemopoietic cells. Gullberg U; Nilsson E; Sarngadharan MG; Olsson I Blood; 1986 Dec; 68(6):1333-8. PubMed ID: 3490886 [TBL] [Abstract][Full Text] [Related]
9. Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60. Harris PE; Ralph P; Gabrilove J; Welte K; Karmali R; Moore MA Cancer Res; 1985 Jul; 45(7):3090-5. PubMed ID: 2988760 [TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells. Brown TJ; Lioubin MN; Marquardt H J Immunol; 1987 Nov; 139(9):2977-83. PubMed ID: 3117884 [TBL] [Abstract][Full Text] [Related]
11. Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). Kupper T; Flood P; Coleman D; Horowitz M J Immunol; 1987 Jun; 138(12):4288-92. PubMed ID: 2953804 [TBL] [Abstract][Full Text] [Related]
12. The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Xu W; Seiter K; Feldman E; Ahmed T; Chiao JW Blood; 1996 Jun; 87(11):4502-6. PubMed ID: 8639816 [TBL] [Abstract][Full Text] [Related]
13. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12). Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907 [TBL] [Abstract][Full Text] [Related]
14. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Burton JD; Bamford RN; Peters C; Grant AJ; Kurys G; Goldman CK; Brennan J; Roessler E; Waldmann TA Proc Natl Acad Sci U S A; 1994 May; 91(11):4935-9. PubMed ID: 8197160 [TBL] [Abstract][Full Text] [Related]
15. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223 [TBL] [Abstract][Full Text] [Related]
16. Biochemical characteristics of a human myeloid leukemia cell differentiation factor. Xu W; Chiao JW Prep Biochem Biotechnol; 1996 Feb; 26(1):21-30. PubMed ID: 8744419 [TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a T lymphocyte-derived differentiation inducing factor for the myeloid leukemic cell line HL-60. Olsson IL; Sarngadharan MG; Breitman TR; Gallo RC Blood; 1984 Mar; 63(3):510-7. PubMed ID: 6607753 [TBL] [Abstract][Full Text] [Related]
19. A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination. Proust JJ; Buchholz MA; Nordin AA J Immunol; 1985 Jan; 134(1):390-6. PubMed ID: 3871110 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3. Smith CA; Rennick DM Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1857-61. PubMed ID: 2937061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]